Ahmed Safia K, Keole Sameer R
Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ 85054, USA.
Cancers (Basel). 2023 Aug 25;15(17):4269. doi: 10.3390/cancers15174269.
Adolescent and young adult cancer patients are at high risk of developing radiation-associated side effects after treatment. Proton beam radiation therapy might reduce the risk of these side effects for this population without compromising treatment efficacy.
We review the current literature describing the utility of proton beam radiation therapy in the treatment of central nervous system tumors, sarcomas, breast cancer and Hodgkin lymphoma for the adolescent and young adult cancer population.
Proton beam radiation therapy has utility for the treatment of certain cancers in the young adult population. Preliminary data suggest reduced radiation dose to normal tissues, which might reduce radiation-associated toxicities. Research is ongoing to further establish the role of proton therapy in this population.
This report highlights the potential utility of proton beam radiation for certain adolescent young adult cancers, especially with reducing radiation doses to organs at risk and thereby potentially lowering risks of certain treatment-associated toxicities.
青少年和青年癌症患者在治疗后发生辐射相关副作用的风险很高。质子束放射治疗可能会降低该人群出现这些副作用的风险,同时不影响治疗效果。
我们回顾了当前描述质子束放射治疗在青少年和青年癌症人群中治疗中枢神经系统肿瘤、肉瘤、乳腺癌和霍奇金淋巴瘤的效用的文献。
质子束放射治疗对青年人群中的某些癌症有治疗作用。初步数据表明对正常组织的辐射剂量降低,这可能会减少辐射相关毒性。正在进行研究以进一步确定质子治疗在该人群中的作用。
本报告强调了质子束辐射对某些青少年和青年癌症的潜在效用,特别是在降低对危险器官的辐射剂量从而可能降低某些治疗相关毒性风险方面。